MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, URGN has $185,046K in assets. $300,454K in debts. $90,039K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
398.98%
Quick Ratio
379.24%
Cash Ratio
213.14%
Debt to Asset Ratio
162.37%
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Prepaid forward obligation
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
90,039 92,904
Marketable securities
36,994 64,050
Restricted cash
1,347 1,082
Accounts receivable, net
19,703 19,649
Inventories
8,341 7,128
Prepaid expenses and other current assets
12,122 12,055
Total current assets
168,546 196,868
Property and equipment, gross
5,208 -
Less accumulated depreciation and amortization
4,513 -
Property and equipment, net
695 688
Restricted deposit
177 177
Right-of-use assets, operating and finance leases
8,489 5,551
Marketable securities
380 4,632
Other non-current assets
6,759 801
Total assets
185,046 208,717
Accounts payable and accrued expenses
26,173 30,962
Employee related accrued expenses
11,114 11,646
Other liabilities, current
4,957 4,940
Total current liabilities
42,244 47,548
Prepaid forward obligation
126,067 124,833
Long-term debt
122,111 122,508
Lease, liabilities, noncurrent
6,241 3,413
Uncertain tax positions liability
3,791 3,791
Total liabilities
300,454 302,093
Ordinary shares, nis 0.01 par value, 100,000,000 shares authorized at september 30, 2025 and december 31, 2024 46,781,211 and 42,231,746 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
128 126
Additional paid-in capital
817,793 806,497
Retained Earnings Accumulated Deficit
--900,005
Accumulated deficit
-933,352 -900,000
Accumulated other comprehensive income
23 6
Total shareholders' deficit
-115,408 -93,376
Total liabilities and shareholders' deficit
185,046 208,717
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Property and equipment,gross$5,208K Prepaid expenses andother current assets$12,122K Inventories$8,341K Accounts receivable, net$19,703K Restricted cash$1,347K Marketable securities$36,994K Cash and cashequivalents$90,039K Other non-currentassets$6,759K Marketable securities$380K Right-of-use assets,operating and finance...$8,489K Restricted deposit$177K Property and equipment,net$695K Total current assets$168,546K Less accumulateddepreciation and...$4,513K Total assets$185,046K Accumulated deficit-$933,352K Total liabilities andshareholders' deficit$185,046K Total shareholders'deficit-$115,408K Accumulated othercomprehensive income$23K Additional paid-in capital$817,793K Ordinary shares, nis 0.01par value,...$128K Total liabilities$300,454K Uncertain tax positionsliability$3,791K Lease, liabilities,noncurrent$6,241K Long-term debt$122,111K Prepaid forwardobligation$126,067K Total currentliabilities$42,244K Other liabilities,current$4,957K Employee related accruedexpenses$11,114K Accounts payable andaccrued expenses$26,173K

UroGen Pharma Ltd. (URGN)

UroGen Pharma Ltd. (URGN)